More thyroid cancers were detected soon after starting a GLP-1 receptor agonist than other diabetes drugs, a secondary analysis of a target trial emulation of a comparative effectiveness study found.

The good news is that the risk for thyroid cancer linked to GLP-1 drugs appears low, but higher detections in the first year, ...

Thyroid cancer is a disease in which malignant (cancer) cells form in the tissues of the thyroid gland. In 2020, there were ...

In 2023, research on mice and rats suggested semaglutide — the powerful ingredient behind Wegovy and Ozempic — could raise the risk of one type of thyroid cancer: medullary thyroid cancer (MTC). Last ...

Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor ...

Blood tests are also used to monitor thyroid cancers. Medullary thyroid cancer accounts for around 5% of all thyroid cancer cases and is categorized into two types: sporadic (not inherited) and ...

Of note, a decreased risk for thyroid cancer was observed among female (HR, 0.62) vs male GLP-1 RA users (HR, 1.32). An analysis of medullary thyroid cancer was not possible due to the low number ...

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

From the reveal of NBA star Dwyane Wade’s cancer surgery to a Bachelorette star on her husband’s cancer diagnosis, here is ...

“Further, given that thyroid cancer, in particular medullary thyroid cancer, is a rare event, future studies should leverage data from multiple large populations to ensure there is sufficient ...

In 2023, research on mice and rats suggested semaglutide — the powerful ingredient behind Wegovy and Ozempic — could raise the risk of one type of thyroid cancer: medullary thyroid cancer (MTC).